Walters et al. [13] also reported that MCT1 mRNA expression levels were significantly higher in MM plasma cells than MGUS plasma cells, and that MCT1 expression was correlated with resistance to chemotherapy. This evidence concerns the gene SLC16A1 and Miyoshi myopathy.